Andrew Rizzo, DO, FAAEM: No financial relationships to disclose
The session will review the biochemistry and a better understanding of the endocannabinoid system when activated by cannabis consumption. This will then lead into discussing the drugs patients typically use/are given in the Emergency Department and how the patient's cannabis consumption might affect dosing/metabolism. I will finish the lecture on how EM providers can make their patients feel comfortable in discussing their cannabis use free of stigmatization to avoid future medication interactions.
Better understand how cannabis interacts on our patient's endocannabinoid system and what physiologic affects manifest from cannabis consumption
Determine which medications prescribed/given in the ED might interact with a patient's cannabis consumption and how to dose medications differently (i.e. propofol, warfarin, seizure meds...)
Talk with their patients free a stigmatization to allow patients to be fully honest in their consumption habits.